Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on June 23, 2026

Jun. 23, 2026

Integra LifeSciences Announces Key Executive Appointments

Indeterminate GlobeNewswire

Jun. 23, 2026

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Indeterminate GlobeNewswire

Jun. 23, 2026

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Indeterminate GlobeNewswire

Jun. 23, 2026

Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Jun. 23, 2026

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

Indeterminate GlobeNewswire

Jun. 23, 2026

Corxel Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Trial of CX11 in Obese and Overweight U.S. Adults

Indeterminate GlobeNewswire

Jun. 23, 2026

IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification

Indeterminate GlobeNewswire

Jun. 23, 2026

Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections

Indeterminate GlobeNewswire

Jun. 23, 2026

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

Indeterminate GlobeNewswire

Jun. 23, 2026

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Indeterminate GlobeNewswire

Jun. 23, 2026

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer 

Indeterminate GlobeNewswire

Jun. 23, 2026

Persephone Biosciences’ Science-Backed Infant and Toddler Synbiotics Now Available on Amazon

Indeterminate GlobeNewswire

Jun. 23, 2026

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Indeterminate GlobeNewswire

Jun. 23, 2026

Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors

Indeterminate GlobeNewswire

Jun. 23, 2026

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Indeterminate GlobeNewswire

Jun. 23, 2026

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Jun. 23, 2026

Plus Therapeutics to Provide Business Update Call on June 30, 2026

Indeterminate GlobeNewswire

Jun. 23, 2026

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Indeterminate GlobeNewswire

Jun. 23, 2026

Cytonus Therapeutics Becomes Axiom Biosciences, Pairing Its Regenerative Medicine Programs With AI-Enabled Drug Design

Indeterminate GlobeNewswire

Jun. 23, 2026

Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers

Indeterminate GlobeNewswire